A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- Biological: Albumin 5%Biological: Albumin 20%Biological: Immunoglobulin
- First Posted Date
- 2012-03-22
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 347
- Registration Number
- NCT01561053
- Locations
- 🇺🇸
Northern California Research, Sacramento, California, United States
🇺🇸Mountain View Clinical Research, Inc, Denver, Colorado, United States
🇺🇸Howard University, Washington, District of Columbia, United States
Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"
- Conditions
- Liver CirrhosisLiver Failure
- Interventions
- Procedure: Plasma exchange with albumin
- First Posted Date
- 2010-09-15
- Last Posted Date
- 2019-02-07
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 12
- Registration Number
- NCT01201720
- Locations
- 🇪🇸
Hospital Clínic of Barcelona, Barcelona, Spain
Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
- Conditions
- Hepatitis BLiver Transplantation
- Interventions
- First Posted Date
- 2010-05-26
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 15
- Registration Number
- NCT01131065
- Locations
- 🇮🇹
A.O.U. Policlinico Università di Modena e Reggio Emilia, Modena, Italy
🇮🇹Az. Ospedaliera Universitaria di Padova, Padova, Italy
🇮🇹Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.
- First Posted Date
- 2009-08-31
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 33
- Registration Number
- NCT00968695
- Locations
- 🇪🇸
Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸Hospital del Mar, Barcelona, Spain
🇪🇸Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation
- Conditions
- Hepatitis B, Chronic
- Interventions
- Drug: intramuscular hepatitis B virus immune globulin
- First Posted Date
- 2009-05-08
- Last Posted Date
- 2009-05-08
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 18
- Registration Number
- NCT00895713
- Locations
- 🇮🇹
Cisanello Hospital. (University of Pisa)., Pisa, Italy
🇮🇹Ospedaliera Molinette, Torino, Italy
Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation
- Conditions
- Hepatitis B, Chronic
- Interventions
- Drug: Specific intravenous anti-hepatitis B immunoglobulin
- First Posted Date
- 2009-02-06
- Last Posted Date
- 2009-02-06
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 20
- Registration Number
- NCT00838071
- Locations
- 🇪🇸
Hospital Clínic de Barcelona, Barcelona, Spain
🇪🇸Hospital Vall d'Hebron, Barcelona, Spain
🇪🇸Hospital Universitario 12 de Octubre, Madrid, Spain
Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
- Conditions
- Acquired Antithrombin III DeficiencyCoronary Artery Bypass
- Interventions
- First Posted Date
- 2009-01-15
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 200
- Registration Number
- NCT00823082
- Locations
- 🇮🇹
IRCCS Policlinico San Donato, Milano, Lombardy, Italy
Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid
- Conditions
- Alzheimer's Disease
- Interventions
- Other: ControlBiological: Albutein 5%
- First Posted Date
- 2008-08-27
- Last Posted Date
- 2016-06-14
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 42
- Registration Number
- NCT00742417
- Locations
- 🇺🇸
Howard University, Washington, District of Columbia, United States
🇺🇸Mid-Atlantic Geriatric/ARC, Manchester Township, New Jersey, United States
🇪🇸Fundació ACE, Barcelona, Catalunya, Spain
Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura
- Conditions
- Immune (Idiopathic) Thrombocytopenic Purpura
- Interventions
- Biological: IGIV3I Grifols
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2016-02-08
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 18
- Registration Number
- NCT00699140
- Locations
- 🇷🇺
Federal Research Clinical Centre of Pediatric Hematology, Oncology and Immunology Roszdrava, Moscow, Russian Federation
🇷🇺Haematology Research Centre of Russian Academy of Medical Science, Moscow, Russian Federation
🇪🇸Hospital General Vall d´Hebron, Barcelona, Spain
Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis
- Conditions
- Target Bleeding Site During Peripheral Vascular Surgery
- Interventions
- Procedure: Manual CompressionBiological: FS Grifols
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2016-01-25
- Lead Sponsor
- Instituto Grifols, S.A.
- Target Recruit Count
- 239
- Registration Number
- NCT00684047
- Locations
- 🇨🇦
St. Boniface General Hospital, Winnipeg, Manitoba, Canada
🇨🇦Schulich School of Medicine, London Health Sciences Center, London, Ontario, Canada
🇨🇦Ottawa Hospital, Ottawa, Ontario, Canada